| Application no. and date | 20192145.9 (espacenet) (Federated) (European Patent Register), 20130702 | | Patent/reg. no. and date | DK/EP 3795592, 20240724 | | Publication date | 20210324 | | Priority no. and date | US 201261667058 P, 20120702 | | EP pub. no. and date |
EP 3795592 20210324 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | PU281289DKQ | | Inventor | LONBERG, Nils, c/o Bristol-Myers Squibb Company
700 Bay Road
Redwood City, CA 94063, US,
SRINIVASAN, Mohan, c/o Bristol-Myers Squibb Company
700 Bay Road
Redwood City, CA 94063, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 45/06 (2006.01) , A61P 31/12 (2006.01) , A61P 35/00 (2006.01) , A61P 37/02 (2006.01) , A61P 37/04 (2006.01) , C07K 16/28 (2006.01) | | Title | OPTIMERING AF ANTISTOFFER, DER BINDER LYMFOCYTAKTIVERINGSGEN-3 (LAG-3), OG
ANVENDELSER DERAF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
